Join
Live feed
·
PRReleasevia Quantisnow
Soleno Therapeutics Inc. logo

Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial Results

ByQuantisnow·Wall Street's wire, on your screen.
SLNO· Soleno Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLNO (Soleno Therapeutics Inc.) and more on Quantisnow.